Kolexia
Decot Veronique
Pharmacien
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
69 Activités
23 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies virales Infections à Adenoviridae Maladie du greffon contre l'hôte COVID-19 Inflammation Syndromes lymphoprolifératifs Infections humaines à adénovirus Virémie Lésion pulmonaire aigüe

Industries

EXAFIELD
1 collaboration(s)
Dernière en 2022
CellProthera
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
HemaSphere   27 janvier 2024
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial.
Frontiers in medicine   29 août 2023
Scale-Up of Academic Mesenchymal Stromal Cell Production.
Journal of clinical medicine   30 juin 2023
A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Cytotherapy   17 avril 2023
Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input.
Cancers   04 février 2023
MSC-COVID19: Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial
Essai Clinique (CHU Nancy)   28 octobre 2021
Role of an academic network in the use and survey of an advanced therapy medicinal product under hospital exemption for adoptive immunotherapy of refractory viral infections
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells.
Critical reviews in oncology/hematology   16 février 2021
Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption
Abstracts from the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)   01 décembre 2020
Mesenchymal Stem/stromal Cell Production Compliant with Good Manufacturing Practice: Comparison Between Bone Marrow and Wharton’s Jelly
Abstracts from the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)   01 décembre 2020